Capstone Partners, together with Oaklins Switzerland, served as a financial advisor to Precipart in connection with a strategic investment from KKR.
Precipart, founded in 1950 by the Laubscher family, is headquartered in Switzerland and produces highly engineered precision components and assemblies for medical devices as well as aerospace and industrial markets.
The Company supports customers from concept to serial production, with major product offerings across precision machining, micro-mechanical components, assemblies, gear systems, motion solutions, technical ceramics and advanced 3D printing.
KKR is a leading global investment firm and is investing in Precipart through its Health Care Strategic Growth Fund, which focuses on high-growth healthcare companies.
